Ocugen, Inc

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN.

CEO

Shankar Musunuri

CEOShankar Musunuri

Employees

Employees56

Headquarters

Malvern, Pennsylvania

HeadquartersMalvern, Pennsylvania

Founded

2013

Founded2013

Employees

Employees56

OCGN Key Statistics

Market cap

404.98M

Market cap404.98M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

5.85M

Average volume5.85M

High today

$1.88

High today$1.88

Low today

$1.79

Low today$1.79

Open price

$1.81

Open price$1.81

Volume

5.13M

Volume5.13M

52 Week high

$17.65

52 Week high$17.65

52 Week low

$1.67

52 Week low$1.67

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

OCGN Earnings

-$0.13

-$0.09

-$0.04

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 11, Pre-Market

ActualExpected Nov 11, Pre-Market